December 16, 2022
Cytalux, an imaging agent developed at Purdue by researcher Phil Low, will improve the precision of surgery to remove lung cancer tumors. By attaching a fluorescent dye to a specific vitamin, surgeons can take advantage of a cancer cell's appetite to essentially highlight itself for removal. Low conducts his research as part of the Purdue Center for Cancer Research, bringing together more than 110 researchers who study cancer at the cellular level.
December 16, 2022
To address the overdose crisis in the United States, the National Institutes of Health has established a research network that will test harm reduction strategies in different community settings to inform efforts to help save lives. The harm reduction research network’s efforts build on existing harm reduction research, and represent the largest pool of funding from NIH to date to study harm reduction strategies to address overdose deaths.
December 1, 2022
The tiny Scottish terrier may be making big waves in helping detect early signs of bladder cancer in humans and dogs.
Purdue Research:Dogs May Be Key in Early Bladder Cancer Detection
November 21, 2022
Cancer strikes without warning. Genetics can explain some of it, as well as environmental and lifestyle conditions. But there is no surefire way to predict who will develop cancer. That tragedy holds true for both humans and their closest domestic companions: dogs.
Purdue News: Man’s best friend leads the way to early cancer detection
November 18, 2022
Moira Gunn, Purdue alumna and host of National Public Radio’s “Tech Nation” and “BioTech Nation,” will discuss how biotechnology relates to women’s health, her personal career path from engineer to award-winning radio journalist and media host, and her experiences in balancing work and life, in a virtual event at 6:30 p.m., Nov. 30.
WGHI News: Moira Gunn to talk biotech, women’s health and career-life balance
November 17, 2022
Cancer that splits and develops in new organs around the body becomes significantly more difficult to fight. Now, researchers at Chalmers have shown that these metastatic cancers, that spread from the original, adapt their metabolism to the tissue in which they grow. The discovery represents a breakthrough for the understanding of metastatic cancer and is an important piece of the puzzle in the search for more effective treatments.
November 17, 2022
When cancer strikes an adult under the age of 50, doctors call it an early-onset case. These cancers at younger ages are becoming more common.
A global epidemic of cancer among people younger than 50 could be emerging
November 16, 2022
Less than half of mums meet the recommended levels of moderate-to-vigorous physical activity -- and mothers of younger children manage to do the least, researchers have found.
Mums' activity levels may depend on number and ages of children
November 16, 2022
Researchers are developing skin-like electronics paired with artificial intelligence for health monitoring and diagnosis.
Skin-like electronics could monitor your health continuously
November 16, 2022
Two new studies reveal how bacteria infiltrate tumors and could be helping tumors progress and spread and suggest a link between oral health and cancer, as microbes in the mouth are associated with cancers elsewhere in the body. The two articles focus on an oral bacterium called Fusobacterium nucleatum, which has been linked to colorectal cancer.
How bacteria could help tumors progress and resist treatment
